Annual report pursuant to Section 13 and 15(d)

Cover

v3.24.1
Cover - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Mar. 20, 2024
Jun. 30, 2023
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2023    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2023    
Current Fiscal Year End Date --12-31    
Entity File Number 001-41463    
Entity Registrant Name bioAffinity Technologies, Inc.    
Entity Central Index Key 0001712762    
Entity Tax Identification Number 46-5211056    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 22211 W Interstate 10    
Entity Address, Address Line Two Suite 1206    
Entity Address, City or Town San Antonio    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 78257    
City Area Code (210)    
Local Phone Number 698-5334    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Elected Not To Use the Extended Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 14.0
Entity Common Stock, Shares Outstanding   11,514,354  
Documents Incorporated By Reference Portions of the registrant’s definitive proxy statement relating to the 2024 annual meeting of stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such definitive proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended December 31, 2023.    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Auditor Name WithumSmith+Brown, PC    
Auditor Location New York, New York    
Auditor Firm ID 100    
Common Stock Par Value 0.007 Per Share [Member]      
Title of 12(b) Security Common stock, par value $0.007 per share    
Trading Symbol BIAF    
Security Exchange Name NASDAQ    
Tradeable Warrants To Purchase Common Stock [Member]      
Title of 12(b) Security Tradeable Warrants to purchase Common Stock    
Trading Symbol BIAFW    
Security Exchange Name NASDAQ